These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A Novel Strategy to Identify Haematology Patients at High Risk of Developing Aspergillosis. Griffiths JS; White PL; Thompson A; da Fonseca DM; Pickering RJ; Ingram W; Wilson K; Barnes R; Taylor PR; Orr SJ Front Immunol; 2021; 12():780160. PubMed ID: 34975870 [TBL] [Abstract][Full Text] [Related]
6. Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field. Douglas AP; Slavin MA Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1165-1177. PubMed ID: 27710140 [TBL] [Abstract][Full Text] [Related]
7. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study. Harrison N; Mitterbauer M; Tobudic S; Kalhs P; Rabitsch W; Greinix H; Burgmann H; Willinger B; Presterl E; Forstner C BMC Infect Dis; 2015 Dec; 15():584. PubMed ID: 26715563 [TBL] [Abstract][Full Text] [Related]
9. Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders. Qiu KY; Liao XY; Fang JP; Xu HG; Li Y; Huang K; Zhou DH Transpl Infect Dis; 2019 Jun; 21(3):e13066. PubMed ID: 30859662 [TBL] [Abstract][Full Text] [Related]
10. Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients. Piñana JL; Gómez MD; Montoro J; Lorenzo I; Pérez A; Giménez E; González-Barberá EM; Carretero C; Guerreiro M; Salavert M; Sanz G; Hernández-Boluda JC; Borrás R; Sanz J; Solano C; Navarro D Transpl Infect Dis; 2019 Oct; 21(5):e13158. PubMed ID: 31402532 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center. Lum L; Lee A; Vu M; Strasser S; Davis R Transpl Infect Dis; 2020 Dec; 22(6):e13361. PubMed ID: 32510755 [TBL] [Abstract][Full Text] [Related]
12. Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial. Wan L; Zhang Y; Lai Y; Jiang M; Song Y; Zhou J; Zhang Z; Duan X; Fu Y; Liao L; Wang C J Clin Oncol; 2015 Dec; 33(34):3999-4006. PubMed ID: 26392095 [TBL] [Abstract][Full Text] [Related]
13. Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation. Sun Y; Xu L; Liu D; Zhang X; Han W; Wang Y; Chen H; Chen Y; Wang F; Wang J; Ji Y; Tang F; Liu K; Huang XJ Clin Microbiol Infect; 2013 Nov; 19(11):1029-34. PubMed ID: 23565830 [TBL] [Abstract][Full Text] [Related]
14. Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects. Akan H; Antia VP; Kouba M; Sinkó J; Tănase AD; Vrhovac R; Herbrecht R J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii5-16. PubMed ID: 24155144 [TBL] [Abstract][Full Text] [Related]
15. Association between CMV and Invasive Fungal Infections After Autologous Stem Cell Transplant in Lymphoproliferative Malignancies: Opportunistic Partnership or Cause-Effect Relationship? Marchesi F; Pimpinelli F; Di Domenico EG; Renzi D; Gallo MT; Regazzo G; Rizzo MG; Gumenyuk S; Toma L; Marino M; Cordone I; Cantonetti M; Liberati AM; Montanaro M; Ceribelli A; Prignano G; Palombi F; Romano A; Papa E; Pisani F; Spadea A; Arcese W; Ensoli F; Mengarelli A Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893777 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China. Liu J; Huang H; Li Y; Liu L; Li J; Liu Z; Lu J; Ouyang J; Song Y; Zhou D; Ren H; Ma J; Wang C; Yu L; Zhou J; Wang J; Xiao Y; Huang X; Li J Tumour Biol; 2016 Jun; 37(6):7893-900. PubMed ID: 26700667 [TBL] [Abstract][Full Text] [Related]
17. Clinical performance of metagenomic next-generation sequencing for diagnosis of invasive fungal disease after hematopoietic cell transplant. Zhang X; Zhang L; Li Y; Wang N; Zhang Y Front Cell Infect Microbiol; 2024; 14():1210857. PubMed ID: 38590441 [TBL] [Abstract][Full Text] [Related]
18. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation. Herbrecht R; Caillot D; Cordonnier C; Auvrignon A; Thiébaut A; Brethon B; Michallet M; Mahlaoui N; Bertrand Y; Preziosi P; Ruiz F; Gorin NC; Gangneux JP J Antimicrob Chemother; 2012 Nov; 67(11):2731-8. PubMed ID: 22850692 [TBL] [Abstract][Full Text] [Related]
19. Antifungal agents for secondary prophylaxis based on response to initial antifungal therapy in allogeneic hematopoietic stem cell transplant recipients with prior pulmonary aspergillosis. Liu Q; Lin R; Sun J; Xiao Y; Nie D; Zhang Y; Huang F; Fan Z; Zhou H; Jiang Q; Zhang F; Zhai X; Xu D; Wei Y; Song J; Li Y; Feng R Biol Blood Marrow Transplant; 2014 Aug; 20(8):1198-203. PubMed ID: 24769013 [TBL] [Abstract][Full Text] [Related]
20. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study. Kuster S; Stampf S; Gerber B; Baettig V; Weisser M; Gerull S; Medinger M; Passweg J; Schanz U; Garzoni C; Berger C; Chalandon Y; Mueller NJ; van Delden C; Neofytos D; Khanna N; Transpl Infect Dis; 2018 Dec; 20(6):e12981. PubMed ID: 30144374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]